4-butyrolactone has been researched along with vanoxerine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, JB; Dijkstra, D; Grol, CJ; Horn, AS; Mulder, TB; Wiechers, JW | 1 |
| Andersson, DR; Nissbrandt, H; Shahabi, HN | 1 |
2 other study(ies) available for 4-butyrolactone and vanoxerine
| Article | Year |
|---|---|
Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
Topics: 4-Butyrolactone; Animals; Apomorphine; Binding, Competitive; Corpus Striatum; Dopamine; In Vitro Techniques; Male; Motor Activity; Naphthalenes; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Neurotransmitter; Spiperone; Substantia Nigra; Synaptosomes; Tetrahydronaphthalenes | 1987 |
Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.
Topics: 4-Butyrolactone; Adrenergic alpha-Agonists; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Extracellular Space; Free Radicals; GABA Modulators; Hydroxybenzoates; In Vitro Techniques; Isoflurane; Ketamine; Male; Microdialysis; Parabens; Piperazines; Rats; Rats, Sprague-Dawley; Reserpine; Substantia Nigra; Synaptic Transmission; Tetrodotoxin; Xylazine | 2008 |